Screening Tags Alerts

Hemab Therapeutics Holdings, Inc.

COAG·NASDAQ·$27.84Share Price as of 11/2·$56MMarket Cap as of 11/2

Financials

10-QQuarter ended 06/30/2608/11/26 10-QQuarter ended 03/31/2605/21/26

Disclosures

8-KCurrent report09/24/26 8-KCurrent report08/11/26 8-KCurrent report05/21/26 8-KCurrent report05/11/26 8-KCurrent report05/04/26

Prospectuses and Registrations

S-8Registration of securities for employees05/04/26 424B4Prospectus05/01/26 S-1/ARegistration statement (amended)04/30/26 S-1MEFProspectus / registration04/30/26 S-1/ARegistration statement (amended)04/28/26

Proxies

No matching filings.

Ownership

Form 3Initial insider ownership09/25/26 Form 4Insider transaction09/25/26 SC 13GBeneficial ownership08/14/26 SC 13GBeneficial ownership08/14/26 SC 13GBeneficial ownership08/12/26

Other

CERTCEO/CFO certification04/30/26 EFFECTRequest for effectiveness04/30/26 8-A12B8-A12B04/27/26 DRS/ADRS/A04/02/26 DRSDRS02/27/26

Latest Filings

8-KCurrent report09/24/26 10-QQuarter ended 06/30/2608/11/26 8-KCurrent report08/11/26 10-QQuarter ended 03/31/2605/21/26 8-KCurrent report05/21/26

Ownership

Form 3Initial insider ownership09/25/26 Form 4Insider transaction09/25/26 SC 13GBeneficial ownership08/14/26 SC 13GBeneficial ownership08/14/26 SC 13GBeneficial ownership08/12/26

Baxion © 2026
Terms
Privacy
Contact